Home > Healthcare & Medical Devices > Pet Cancer Therapeutics Market > Table of Contents
Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Pet cancer therapeutics industry 360° synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Therapy trends
2.1.3 Route of administration trends
2.1.4 Species trends
2.1.5 Applications trends
2.1.6 Regional trends
Chapter 3 Pet Cancer Therapeutics Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising prevalence of pet cancer
3.3.1.2 Growing awareness among pet owners regarding pet diseases
3.3.1.3 Increasing pet care expenditure
3.3.1.4 Technological advancements in pet cancer therapeutics including cancer immunotherapy
3.3.1.5 High medical unmet need and strong potential
3.3.2 Industry pitfalls & challenges
3.3.2.1 Side effects associated with pet cancer therapeutics
3.3.2.2 Lack of veterinary oncologists
3.4 Growth potential analysis
3.4.1 By therapy
3.4.2 By route of administration
3.4.3 By species
3.4.4 By application
3.5 COVID- 19 impact analysis
3.6 Product pipeline analysis
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 European Union
3.7.3 Brazil
3.7.4 Australia
3.7.5 India
3.8 Porter's analysis
3.9 Competitive landscape, 2021
3.9.1 Company matrix analysis, 2021
3.10 PESTLE Analysis
Chapter 4 Pet Cancer Therapeutics Market, By Therapy
4.1 Key segment trends
4.2 Chemotherapy
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Immunotherapy
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.4 Targeted therapy
4.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.5 Combination therapy
4.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Pet Cancer Therapeutics Market, By Route of Administration
5.1 Key segment trends
5.2 Oral
5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Injection
5.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Pet Cancer Therapeutics Market, By Species
6.1 Key segment trends
6.2 Dogs
6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Cats
6.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Pet Cancer Therapeutics Market, By Application
7.1 Key segment trends
7.2 Lymphoma
7.2.1 Market size, by region, 2017 - 2030 (USD Million)
7.3 Mast cell cancer
7.3.1 Market size, by region, 2017 - 2030 (USD Million)
7.4 Melanoma
7.4.1 Market size, by region, 2017 - 2030 (USD Million)
7.5 Mammary and squamous cell cancer
7.5.1 Market size, by region, 2017 - 2030 (USD Million)
7.6 Others
7.6.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Pet Cancer Therapeutics Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2017 - 2030 (USD Million)
8.2.2 Market size, by therapy, 2017 - 2030 (USD Million)
8.2.3 Market size, by route of administration, 2017 - 2030 (USD Million)
8.2.4 Market size, by species, 2017 - 2030 (USD Million)
8.2.5 Market size, by application, 2017 - 2030 (USD Million)
8.2.6 U.S.
8.2.6.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.2.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.2.6.3 Market size, by species, 2017 - 2030 (USD Million)
8.2.6.4 Market size, by application, 2017 - 2030 (USD Million)
8.2.7 Canada
8.2.7.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.2.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.2.7.3 Market size, by species, 2017 - 2030 (USD Million)
8.2.7.4 Market size, by application, 2017 - 2030 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2017 - 2030 (USD Million)
8.3.2 Market size, by therapy, 2017 - 2030 (USD Million)
8.3.3 Market size, by route of administration, 2017 - 2030 (USD Million)
8.3.4 Market size, by species, 2017 - 2030 (USD Million)
8.3.5 Market size, by application, 2017 - 2030 (USD Million)
8.3.6 Germany
8.3.6.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.3.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.3.6.3 Market size, by species, 2017 - 2030 (USD Million)
8.3.6.4 Market size, by application, 2017 - 2030 (USD Million)
8.3.7 UK
8.3.7.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.3.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.3.7.3 Market size, by species, 2017 - 2030 (USD Million)
8.3.7.4 Market size, by application, 2017 - 2030 (USD Million)
8.3.8 France
8.3.8.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.3.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.3.8.3 Market size, by species, 2017 - 2030 (USD Million)
8.3.8.4 Market size, by application, 2017 - 2030 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.3.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.3.9.3 Market size, by species, 2017 - 2030 (USD Million)
8.3.9.4 Market size, by application, 2017 - 2030 (USD Million)
8.3.10 Italy
8.3.10.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.3.10.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.3.10.3 Market size, by species, 2017 - 2030 (USD Million)
8.3.10.4 Market size, by application, 2017 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2017 - 2030 (USD Million)
8.4.2 Market size, by therapy, 2017 - 2030 (USD Million)
8.4.3 Market size, by route of administration, 2017 - 2030 (USD Million)
8.4.4 Market size, by species, 2017 - 2030 (USD Million)
8.4.5 Market size, by application, 2017 - 2030 (USD Million)
8.4.6 China
8.4.6.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.4.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.4.6.3 Market size, by species, 2017 - 2030 (USD Million)
8.4.6.4 Market size, by application, 2017 - 2030 (USD Million)
8.4.7 Japan
8.4.7.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.4.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.4.7.3 Market size, by species, 2017 - 2030 (USD Million)
8.4.7.4 Market size, by application, 2017 - 2030 (USD Million)
8.4.8 India
8.4.8.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.4.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.4.8.3 Market size, by species, 2017 - 2030 (USD Million)
8.4.8.4 Market size, by application, 2017 - 2030 (USD Million)
8.4.9 Australia
8.4.9.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.4.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.4.9.3 Market size, by species, 2017 - 2030 (USD Million)
8.4.9.4 Market size, by application, 2017 - 2030 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2017 - 2030 (USD Million)
8.5.2 Market size, by therapy, 2017 - 2030 (USD Million)
8.5.3 Market size, by route of administration, 2017 - 2030 (USD Million)
8.5.4 Market size, by species, 2017 - 2030 (USD Million)
8.5.5 Market size, by application, 2017 - 2030 (USD Million)
8.5.6 Brazil
8.5.6.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.5.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.5.6.3 Market size, by species, 2017 - 2030 (USD Million)
8.5.6.4 Market size, by application, 2017 - 2030 (USD Million)
8.5.7 Mexico
8.5.7.1 Market size, by therapy, 2017 - 2030 (USD Million)
8.5.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
8.5.7.3 Market size, by species, 2017 - 2030 (USD Million)
8.5.7.4 Market size, by application, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
9.1 Competitive dashboard, 2021
9.2 Zoetis, Inc.
9.2.1 Business Overview
9.2.2 Financial Data
9.2.3 Product Landscape
9.2.4 Strategic Outlook
9.2.5 SWOT Analysis
9.3 Elanco Animal Health
9.3.1 Business Overview
9.3.2 Financial Data
9.3.3 Product Landscape
9.3.4 Strategic Outlook
9.3.5 SWOT Analysis
9.4 Boehringer Ingelheim International GmbH
9.4.1 Business Overview
9.4.2 Financial Data
9.4.3 Product Landscape
9.4.4 Strategic Outlook
9.4.5 SWOT Analysis
9.5 Dechra Pharmaceuticals
9.5.1 Business Overview
9.5.2 Financial Data
9.5.3 Product Landscape
9.5.4 Strategic Outlook
9.5.5 SWOT Analysis
9.6 AB Science
9.6.1 Business Overview
9.6.2 Financial Data
9.6.3 Product Landscape
9.6.4 Strategic Outlook
9.6.5 SWOT Analysis
9.7 Qbiotics
9.7.1 Business Overview
9.7.2 Financial Data
9.7.3 Product Landscape
9.7.4 Strategic Outlook
9.7.5 SWOT Analysis
9.8 NovaVive, Inc.
9.8.1 Business Overview
9.8.2 Financial Data
9.8.3 Product Landscape
9.8.4 Strategic Outlook
9.8.5 SWOT Analysis
9.9 ELIAS Animal Health
9.9.1 Business Overview
9.9.2 Financial Data
9.9.3 Product Landscape
9.9.4 Strategic Outlook
9.9.5 SWOT Analysis
Data Tables
TABLE 1 Global pet cancer therapeutics market, 2017 - 2021 (USD Million)
TABLE 2 Global pet cancer therapeutics market, 2022 – 2030 (USD Million)
TABLE 3 Global pet cancer therapeutics market, by therapy, 2017 - 2021 (USD Million)
TABLE 4 Global pet cancer therapeutics market, by therapy, 2022 – 2030 (USD Million)
TABLE 5 Global pet cancer therapeutics market, by route of administration, 2017 - 2021 (USD Million)
TABLE 6 Global pet cancer therapeutics market, by route of administration, 2022 – 2030 (USD Million)
TABLE 7 Global pet cancer therapeutics market, by species, 2017 - 2021 (USD Million)
TABLE 8 Global pet cancer therapeutics market, by species, 2022 – 2030 (USD Million)
TABLE 9 Global pet cancer therapeutics market, by application, 2017 - 2021 (USD Million)
TABLE 10 Global pet cancer therapeutics market, by application, 2022 – 2030 (USD Million)
TABLE 11 Global pet cancer therapeutics market, by region, 2017 - 2021 (USD Million)
TABLE 12 Global pet cancer therapeutics market, by region, 2022 – 2030 (USD Million)
TABLE 13 Industry impact forces
TABLE 14 Chemotherapy market, by region, 2017 - 2021, (USD Million)
TABLE 15 Chemotherapy market, by region, 2022 - 2030, (USD Million)
TABLE 16 Immunotherapy market, by region, 2017 - 2021, (USD Million)
TABLE 17 Immunotherapy market, by region, 2022 - 2030, (USD Million)
TABLE 18 Targeted therapy market, by region, 2017 - 2021, (USD Million)
TABLE 19 Targeted therapy market, by region, 2022 - 2030, (USD Million)
TABLE 20 Combined therapy market, by region, 2017 - 2021, (USD Million)
TABLE 21 Combined therapy market, by region, 2022 - 2030, (USD Million)
TABLE 22 Oral market, by region, 2017 - 2021, (USD Million)
TABLE 23 Oral market, by region, 2022 - 2030, (USD Million)
TABLE 24 Injection market, by region, 2017 - 2021, (USD Million)
TABLE 25 Injection market, by region, 2022 - 2030, (USD Million)
TABLE 26 Dogs market, by region, 2017 - 2021, (USD Million)
TABLE 27 Dogs market, by region, 2022 – 2030, (USD Million)
TABLE 28 Cats market, by region, 2017 - 2021, (USD Million)
TABLE 29 Cats market, by region, 2022 - 2030, (USD Million)
TABLE 30 Lymphoma market, by region, 2017 - 2021, (USD Million)
TABLE 31 Lymphoma market, by region, 2022 - 2030, (USD Million)
TABLE 32 Mast cell cancer market, by region, 2017 - 2021, (USD Million)
TABLE 33 Mast cell cancer market, by region, 2022 - 2030, (USD Million)
TABLE 34 Melanoma market, by region, 2017 - 2021, (USD Million)
TABLE 35 Melanoma market, by region, 2022 - 2030, (USD Million)
TABLE 36 Mammary and squamous cell cancer market, by region, 2017 - 2021, (USD Million)
TABLE 37 Mammary and squamous cell cancer market, by region, 2022 - 2030, (USD Million)
TABLE 38 Others market, by region, 2017 - 2021, (USD Million)
TABLE 39 Others market, by region, 2022 - 2030, (USD Million)
TABLE 40 North America pet cancer therapeutics market, by country, 2017-2021, (USD Million)
TABLE 41 North America pet cancer therapeutics market, by country, 2022-2030, (USD Million)
TABLE 42 North America pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 43 North America pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 44 North America pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 45 North America pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 46 North America pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 47 North America pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 48 North America pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 49 North America pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 50 U.S. pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 51 U.S. pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 52 U.S. pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 53 U.S. pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 54 U.S. pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 55 U.S. pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 56 U.S. pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 57 U.S. pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 58 Canada pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 59 Canada pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 60 Canada pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 61 Canada pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 62 Canada pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 63 Canada pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 64 Canada pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 65 Canada pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 66 Europe pet cancer therapeutics market, by country, 2017-2021, (USD Million)
TABLE 67 Europe pet cancer therapeutics market, by country, 2022-2030, (USD Million)
TABLE 68 Europe pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 69 Europe pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 70 Europe pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 71 Europe pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 72 Europe pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 73 Europe pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 74 Europe pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 75 Europe pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 76 Germany pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 77 Germany pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 78 Germany pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 79 Germany pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 80 Germany pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 81 Germany pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 82 Germany pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 83 Germany pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 84 UK pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 85 UK pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 86 UK pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 87 UK pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 88 UK pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 89 UK pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 90 UK pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 91 UK pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 92 France pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 93 France pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 94 France pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 95 France pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 96 France pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 97 France pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 98 France pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 99 France pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 100 Spain pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 101 Spain pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 102 Spain pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 103 Spain pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 104 Spain pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 105 Spain pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 106 Spain pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 107 Spain pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 108 Italy pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 109 Italy pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 110 Italy pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 111 Italy pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 112 Italy pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 113 Italy pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 114 Italy pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 115 Italy pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 116 Asia Pacific pet cancer therapeutics market, by country, 2017-2021, (USD Million)
TABLE 117 Asia Pacific pet cancer therapeutics market, by country, 2022-2030, (USD Million)
TABLE 118 Asia Pacific pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 119 Asia Pacific pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 120 Asia Pacific pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 121 Asia Pacific pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 122 Asia Pacific pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 123 Asia Pacific pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 124 Asia Pacific pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 125 Asia Pacific pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 126 China pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 127 China pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 128 China pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 129 China pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 130 China pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 131 China pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 132 China pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 133 China pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 134 India pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 135 India pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 136 India pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 137 India pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 138 India pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 139 India pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 140 India pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 141 India pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 142 Japan pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 143 Japan pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 144 Japan pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 145 Japan pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 146 Japan pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 147 Japan pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 148 Japan pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 149 Japan pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 150 Australia pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 151 Australia pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 152 Australia pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 153 Australia pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 154 Australia pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 155 Australia pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 156 Australia pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 157 Australia pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 158 Latin America pet cancer therapeutics market, by country, 2017-2021, (USD Million)
TABLE 159 Latin America pet cancer therapeutics market, by country, 2022-2030, (USD Million)
TABLE 160 Latin America pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 161 Latin America pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 162 Latin America pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 163 Latin America pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 164 Latin America pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 165 Latin America pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 166 Latin America pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 167 Latin America pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 168 Brazil pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 169 Brazil pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 170 Brazil pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 171 Brazil pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 172 Brazil pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 173 Brazil pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 174 Brazil pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 175 Brazil pet cancer therapeutics market, by application, 2022-2030, (USD Million)
TABLE 176 Mexico pet cancer therapeutics market, by therapy, 2017-2021, (USD Million)
TABLE 177 Mexico pet cancer therapeutics market, by therapy, 2022-2030, (USD Million)
TABLE 178 Mexico pet cancer therapeutics market, by route of administration, 2017-2021, (USD Million)
TABLE 179 Mexico pet cancer therapeutics market, by route of administration, 2022-2030, (USD Million)
TABLE 180 Mexico pet cancer therapeutics market, by species, 2017-2021, (USD Million)
TABLE 181 Mexico pet cancer therapeutics market, by species, 2022-2030, (USD Million)
TABLE 182 Mexico pet cancer therapeutics market, by application, 2017-2021, (USD Million)
TABLE 183 Mexico pet cancer therapeutics market, by application, 2022-2030, (USD Million)
Charts & Figures
FIG. 1 Top-down approach
FIG. 2 Breakdown of primary participants
FIG. 3 Pet cancer therapeutics market industry 360o synopsis, 2017 – 2030
FIG. 4 Industry segmentation
FIG. 5 Global pet cancer therapeutics, by region, 2017 - 2030 (USD Million)
FIG. 6 Growth potential analysis, by therapy
FIG. 7 Growth potential analysis, by route of administration
FIG. 8 Growth potential analysis, by species
FIG. 9 Growth potential analysis, by application
FIG. 10 Porter’s analysis
FIG. 11 Company matrix analysis, 2021
FIG. 12 PESTEL analysis
FIG. 13 Key segment trends, by therapy
FIG. 14 Key segment trends, by route of administration
FIG. 15 Key segment trends, by species
FIG. 16 Key segment trends, by application
FIG. 17 Key regional trends
FIG. 18 Strategy dashboard, 2021